Oxford Immunotec announced FDA clearance of the T-SPOT.TB test for use in pediatrics over the age of two
On Sept. 29, 2020, Oxford Immunotec announced that it had received clearance from the U.S. Food and Drug…
-
-
Sinovac’s Coronavac, SARS-CoV-2 vaccine, inactivated, announced approval for phase I/II clinical trial in adolescents and children
On Sept. 23, 2020, Sinovac Biotech announced that the inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences,…
-
Study found that children’s immune response protected against COVID-19
On Sept. 21, 2020, the first study comparing the immune responses of adults and children with COVID-19 has…
-
Evidence suggested children could play a larger role in community spread of COVID-19
On Aug. 20, 2020, in the most comprehensive study of COVID-19 pediatric patients to date, Harvard Medical School…
-
Biotechnology | FDA | Oncology | Rare Disease | Therapeutics
Ultragenyx and Kyowa Kirin Announce U.S. FDA Approval of Crysvita® (burosumab) for Treatment of Tumor-Induced Osteomalacia
On Jun. 18, 2020, Ultragenyx Pharmaceutical and Kyowa Kirin announced that the U.S. Food and Drug Administration (FDA)…
-
Biotechnology | Diagnostics | Disease | FDA | Medical Device | Neurology | Therapeutics
The FDA permitted marketing of first game-based digital therapeutic to improve attention function in children with ADHD
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital…
-
Biotechnology | CDC | FDA | HIV | Therapeutics
The FDA approved drug to treat infants and children with HIV
On June 12, 2020, the U.S. Food and Drug Administration (FDA) approved Tivicay (dolutegravir) tablets and Tivicay PD…
-
Biotechnology | FDA | HIV | Therapeutics
ViiV Healthcare announced FDA approval of the first-ever dispersible tablet formulation of dolutegravir for children living with HIV
On Jun. 12, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
-
NIH funded study to evaluate drugs prescribed to children with COVID-19
On Jun. 10, 2020, researchers funded by the National Institutes of Health (NIH) launched an effort to evaluate…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics
NIH researchers uncovered genes linked to common recurrent fever n children
On Jun. 8, 2020, researchers at the National Human Genome Research Institute announced they had discovered clues to…
-
The FDA approved only drug in U.S. to treat severe malaria
On May 26, 2020, the U.S. Food and Drug Administration (FDA) announced it had approved Amivas’ artesunate for…
-
The FDA approved only drug in the U.S. to treat severe malaria
On May 26, 2020, the U.S. Food and Drug Administration (FDA) approved artesunate for injection to treat severe…
-
Biotechnology | COVID-19 | Disease | Infectious Disease | Measles | Polio | Therapeutics | Vaccine | WHO
At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupted routine vaccination efforts
On May 22, 2020, COVID 19 disrupted life-saving immunization services around the world, putting millions of children –…
-
New study from pandemic epicenter described severe COVID-19 response in children
On May 19, 2020, the Albert Einstein College of Medicine reported that while most children infected with the…
-
Airway Therapeutics announced filing with NIH to evaluate AT-100 as therapy for novel Coronavirus
On May 11, 2020, Airway Therapeutics announced a filing with the Respiratory Diseases Branch of the National Institutes…
-
The FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen
On Apr. 22, 2020, the FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen…
-
Biotechnology | FDA | Oncology | Rare Disease | Therapeutics
FDA approved first therapy for children with debilitating and disfiguring rare disease
On Apr. 10, 2020, the U.S. Food and Drug Administration (FDA) approved selumetinib (KOSELUGO, AstraZeneca) for pediatric patients, 2…
-
Children’s Hospital of Georgia uses Philips’ automated early detection and warning solution to improve pediatric patient deterioration response
On Mar. 25, 2020, Royal Philips announced that Children’s Hospital of Georgia has adopted Philips’ automated early detection…
-
Philips ramped up production of critical health technology products in response to COVID-19 pandemic
On Mar. 22, 2020, Royal Philips announced that it is increasing the production of certain critical care products and…
-
FDA approved Epclusa (Sofosbuvir/Velpatasvir) for children with Chronic Hepatitis C infection
On Mar. 19, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) had approved a supplemental…
-
Dr. Claudia Kleinman, Dr. Nada Jabado, and Dr. Michael Taylor discovered that pediatric brain tumors derive from a genetic event early in cellular development
On Nov. 25, 2019, Dr. Claudia Kleinman, Dr. Nada Jabado, and Dr. Michael Taylor discovered that pediatric brain…
-
UPenn and Novartis end 7-year R&D alliance, will narrow scope of collaboration
On Sept. 16, 2019, Healio reported the 7-year research and development alliance between Novartis and the University of…
-
Genetically modified babies given go ahead by UK ethics body
On Jul. 18, 2018, the Nuffield Council on Bioethics said that changing the DNA of a human embryo…
-
Geneticist Dr. Judith G. Hall was awarded the Rimoin Lifetime Achievement Award
On Apr. 11, 2018, Dr. Judith G. Hall, professor emerita of pediatrics and medical genetics at the University…
-
MMK Foundation donated $1 million to Children’s Health, Southwestern Medical Center
On Feb. 28, 2018, The MMK Foundation, founded by Mark and Marcia King, pledged $1 million to be…
-
OHSU Doernbecher was the first in PNW to be ACS-verified as a Level 1 pediatric trauma center
On Feb. 22, 2018, OHSU Doernbecher Children’s Hospital was verified as a Level 1 Pediatric Trauma Center and…
-
Biotechnology | FDA | Oncology | Therapeutics
FDA approves personalized cellular therapy for advanced leukemia developed at Penn and CHOP
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved a personalized cellular therapy developed by…
-
Biotechnology | CDC | Vaccine
AAP issued policy stating that newborns should routinely receive hepatitis B vaccine within 24 hours of birth
On Aug. 28, 2017, the American Academy of Pediatrics (AAP) issued policy stating that newborns should routinely receive…
-
NIH selected OHSU Knight Cancer Institute to co-lead largest national database for pediatric cancer, rare disease research
On Aug. 15, 2017, the National Institutes of Health’s (NIH) Gabriella Miller Kids First Pediatric Research Program awarded…
-
Marc and Lynne Benioff’s $20 million gift to USC supports research and treatment innovations to fight cancer
On Sept. 29, 2016, University of Southern California (USC) Trustee Marc Benioff ’86 and his wife, Lynne, gifted…
